Show simple item record

dc.contributor.authorBissessor, Naylin
dc.date.accessioned2017-08-02T06:14:55Z
dc.date.available2017-08-02T06:14:55Z
dc.date.issued2015
dc.identifier.issn1179-1470
dc.identifier.doi10.2147/MDER.S49368
dc.identifier.urihttp://hdl.handle.net/10072/124957
dc.description.abstractIn the last decade, percutaneous atrial septal defect (ASD) closure has become the treatment of choice in most clinical presentations of ASD. Percutaneous ASD closure has established procedural safety through operator experience and improved device structure and deliverability. There have also been advances in diagnostic capabilities. Devices have evolved from large bulky meshes to repositionable, minimal residual mesh content that easily endothelializes and conforms well to surrounding structures. Biodegradable technology has been introduced and will be closely watched as a future option. The evolution of ASD closure device usage in the last four decades incorporates development that minimizes a wide range of serious side effects that have been reported over the years. Complications reported in the literature include thrombus formation, air embolization, device embolization, erosions, residual shunts, and nickel hypersensitivity. Modern devices have intermediate to long term data with outcomes that have been favorable. Devices are available in multiple sizes with improved delivery mechanisms to recapture, reposition, and safely close simple and complex ASDs amenable to percutaneous closure. In this review, commonly used devices and deployment procedures are discussed together with a look at devices that show promise for the future.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherDove Medical Press
dc.relation.ispartofpagefrom297
dc.relation.ispartofpageto303
dc.relation.ispartofjournalMedical Devices
dc.relation.ispartofvolume8
dc.subject.fieldofresearchBiomedical Engineering not elsewhere classified
dc.subject.fieldofresearchBiomedical Engineering
dc.subject.fieldofresearchClinical Sciences
dc.subject.fieldofresearchcode090399
dc.subject.fieldofresearchcode0903
dc.subject.fieldofresearchcode1103
dc.titleCurrent perspectives in percutaneous atrial septal defect closure devices
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
dcterms.licensehttp://creativecommons.org/licenses/by-nc/3.0
dc.description.versionVersion of Record (VoR)
gro.facultyGriffith Health, School of Medicine
gro.rights.copyright© 2015 Bissessor. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
gro.hasfulltextFull Text
gro.griffith.authorBissessor, Naylin


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record